Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience

Torok, 1995, Increasing mortality from thrombotic thrombocytopenic purpura in the United States—Analysis of national mortality data, 1968–1991, Am J Hematol, 50, 84, 10.1002/ajh.2830500203

Rock, 2000, Management of thrombotic thrombocytopenic purpura, Br J Haematol, 109, 496, 10.1046/j.1365-2141.2000.01941.x

Moschcowitz, 1924, Hyaline thrombosis of the terminal arterioles and capillaries, Proc NY Pathol Soc, 24, 21

Singer, 1947, Thrombotic thrombocytopenic purpura, Blood, 2, 542, 10.1182/blood.V2.6.542.542

Moake, 2002, Thrombotic microangiopathies, N Engl J Med, 347, 589, 10.1056/NEJMra020528

Moake, 1982, Unusually large plasma factor VIII, N Engl J Med, 307, 1432, 10.1056/NEJM198212023072306

Dent, 1991, Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit, J Clin Invest, 88, 774, 10.1172/JCI115376

Furlan, 1996, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, 87, 4223, 10.1182/blood.V87.10.4223.bloodjournal87104223

Tsai, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235

Furlan, 1997, Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097

Furlan, 1998, Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846

Furlan, 1998, Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202

Tsai, 1998, Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203

Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662

Gerritsen, 2001, Partial amino acid sequence of purified von Willebrand factor-cleaving protease, Blood, 98, 1654, 10.1182/blood.V98.6.1654

Zheng, 2001, Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura, J Biol Chem, 276, 41059, 10.1074/jbc.C100515200

Levy, 2001, Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, 488, 10.1038/35097008

Soejima, 2001, A novel human metalloprotease synthesized in the liver and secreted into the blood, J Biochem (Tokyo), 130, 475, 10.1093/oxfordjournals.jbchem.a003009

Plaimauer, 2002, Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13), Blood, 100, 3626, 10.1182/blood-2002-05-1397

Upshaw, 1978, Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia, N Engl J Med, 298, 1350, 10.1056/NEJM197806152982407

Schulman, 1960, Studies on thrombopoiesis. I: A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency, Blood, 16, 943, 10.1182/blood.V16.1.943.943

Kokame, 2002, Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity, Proc Natl Acad Sci USA, 99, 11902, 10.1073/pnas.172277399

Schneppenheim, 2003, Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP, Blood, 101, 1845, 10.1182/blood-2002-08-2399

Antoine, 2003, ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13, Br J Haematol, 120, 821, 10.1046/j.1365-2141.2003.04183.x

Savasan, 2003, ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity, Blood, 101, 4449, 10.1182/blood-2002-12-3796

Assink, 2003, Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency, Kidney Int, 63, 1995, 10.1046/j.1523-1755.63.6s.1.x

Amorosi, 1966, Thrombotic thrombocytopenic purpura, Medicine (Baltimore), 45, 139, 10.1097/00005792-196603000-00003

Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, 325, 393, 10.1056/NEJM199108083250604

Hénon, 1991, Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study, Presse Med, 20, 1761

Bell, 1991, Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients, N Engl J Med, 325, 398, 10.1056/NEJM199108083250605

George, 2000, How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Blood, 96, 1223, 10.1182/blood.V96.4.1223

Allford, 2003, Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias, Br J Haematol, 120, 556, 10.1046/j.1365-2141.2003.04049.x

Gasser, 1955, Hämolytisch-urämische Syndrome, Schweiz Med Wochenschr, 85, 905

Dundas, 1999, Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak, Lancet, 354, 1327, 10.1016/S0140-6736(99)01251-9

Ruggenenti, 2001, Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, Kidney Int, 60, 831, 10.1046/j.1523-1755.2001.060003831.x

Vesely, 2003, ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Blood, 102, 60, 10.1182/blood-2003-01-0193

Bianchi, 2002, Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders, Blood, 100, 710, 10.1182/blood-2002-02-0344

Kinoshita, 2001, Upshaw-Schulman syndrome revisited, Int J Hematol, 74, 101, 10.1007/BF02982558

Studt, 2003, Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies, Swiss Med Wkly, 133, 325

Studt, 2003, Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma, J Thromb Haemost, 1, 1882, 10.1046/j.1538-7836.2003.00385.x

Cantrell, 1985, Carcinoma-associated hemolytic-uremic syndrome, J Clin Oncol, 3, 723, 10.1200/JCO.1985.3.5.723

Gordon, 1999, Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient, Semin Thromb Hemost, 25, 217, 10.1055/s-2007-994923

Medina, 2001, Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Curr Opin Hematol, 8, 286, 10.1097/00062752-200109000-00004

van der Plas, 1999, von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura, Blood, 93, 3798, 10.1182/blood.V93.11.3798

Tsai, 2001, von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome, Pediatr Res, 49, 653, 10.1203/00006450-200105000-00008

Mori, 2002, Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity, Transfusion, 42, 572, 10.1046/j.1537-2995.2002.00100.x

Elliott, 2003, Posttransplantation thrombotic thrombocytopenic purpura, Mayo Clin Proc, 78, 421, 10.4065/78.4.421

Hunt, 2001, von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome, Thromb Haemost, 85, 975, 10.1055/s-0037-1615949

Veyradier, 2001, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies, Blood, 98, 1765, 10.1182/blood.V98.6.1765

Veyradier, 2003, Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome, J Pediatr, 142, 310, 10.1067/mpd.2003.79

Remuzzi, 2002, von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, Blood, 100, 778, 10.1182/blood-2001-12-0166

Remuzzi, 2003, Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No, J Thromb Haemost, 1, 632, 10.1046/j.1538-7836.2003.00170.x

Tsai, 2003, Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes, J Thromb Haemost, 1, 625, 10.1046/j.1538-7836.2003.00169.x

Loof, 2001, Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura, Br J Haematol, 112, 1087, 10.1046/j.1365-2141.2001.02622-5.x

Moore, 2001, Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders, Blood, 98, 1842, 10.1182/blood.V98.6.1842

Furlan, 2001, Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome, Best Pract Res Clin Haematol, 14, 437, 10.1053/beha.2001.0142

Tandon, 1994, Anti-CD36 antibodies in thrombotic thrombocytopenic purpura, Br J Haematol, 88, 816, 10.1111/j.1365-2141.1994.tb05122.x

Schultz, 1998, Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders, Br J Haematol, 103, 849, 10.1046/j.1365-2141.1998.01070.x

Dong, 2002, ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood, 100, 4033, 10.1182/blood-2002-05-1401

Shumak, 1995, Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group, Ann Intern Med, 122, 569, 10.7326/0003-4819-122-8-199504150-00002

Kappers-Klunne, 1997, Thrombotic thrombocytopenic purpura in 13 Dutch centres, Ned Tijdschr Geneeskd, 141, 1192

Zheng, 2003, Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab, Ann Intern Med, 138, 105, 10.7326/0003-4819-138-2-200301210-00011

Scheiflinger, 2003, Non-neutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura (TTP), Blood, 10.1182/blood-2003-05-1616

George, 2002, Platelets, Hematology (Am Soc Hematol Educ Program), 315, 10.1182/asheducation-2002.1.315